| ||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||
More...
| ||||||||||||||||||||||||||||||||||||
| << Start < Prev 51 52 53 54 55 56 57 58 59 60 Next > End >> | ||||||||||||||||||||||||||||||||||||
| Results 936 - 952 of 1441 | ||||||||||||||||||||||||||||||||||||
More
-
Rexahn Pharmaceuticals Receives AMEX Listing Approval (Business Wire)
ROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, announced today that its common shares have been approved for listing on the American Stock Exchange and are expected to commence trading at the opening of the market on Tuesday, May 27, 2008.
-
New Issue-Idaho Power sells $120 mln first mortgage bonds
Banc of America Securities, JP Morgan, and Wachovia Securities were the joint bookrunning managers for the sale. BORROWER: IDAHO POWER COMPANY AMT $120 MLN COUPON 6.025 PCT MATURITY 7/15/2018 TYPE...